Results 291 to 300 of about 18,672,321 (342)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

RadRepro CBCT: An Open-Access CBCT Phantom Dataset for Improved Standardization and Reproducibility of Radiomics Research. [PDF]

open access: yesSci Data
Hatamikia S   +7 more
europepmc   +1 more source

VIGMA: An Open-Access Framework for Visual Gait and Motion Analytics. [PDF]

open access: yesIEEE Trans Vis Comput Graph
Omar KS   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy